{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:31:44Z","timestamp":1787725904461,"version":"build-2784847793"},"reference-count":91,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T00:00:00Z","timestamp":1748995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Polycystic ovary syndrome (PCOS) is a common endocrine disorder affecting approximately 10% of middle-aged women worldwide. It is characterized by hirsutism, anovulation, and polycystic ovaries. Various factors, including environmental toxins, inflammation, oxidative stress, and insulin resistance, contribute to the progression of this condition. PCOS is also associated with metabolic disturbances, such as abnormal hormone and neurotransmitter metabolism, leading to obesity, hyperandrogenemia, and type 2 diabetes. Among female cancers, breast cancer, endometrial cancer, and ovarian cancer have high incidence rates and pose significant threats to women\u2019s health. Studies suggest a potential link between PCOS and these gynecological cancers. Consequently, hormonal alterations in PCOS patients may influence tumorigenesis and metastasis. Moreover, PCOS is characterized by chronic low-grade inflammation, including dysregulated pro-inflammatory cytokine secretion, increased immune cell proliferation, and endothelial dysfunction. These factors contribute to cancer development, primarily through impaired immune metabolism, preventing effective tumor cell clearance and facilitating metastasis. This review synthesizes current knowledge on the mechanistic links between PCOS and gynecological cancers, focusing on the roles of immune cell dysfunction, aberrant cytokine secretion, and neurotransmitter metabolism. Therapeutic strategies, including hormonal interventions, insulin sensitizers, and lifestyle modifications, may mitigate cancer risk by modulating these pathways. This review highlights critical gaps in understanding PCOS-related oncogenesis and advocates for further research to elucidate molecular mechanisms and optimize clinical management.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1578470","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T05:39:34Z","timestamp":1749015574000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["The relationship between polycystic ovary syndrome and gynecological cancers: neurotransmitter metabolism changes and immune regulation"],"prefix":"10.3389","volume":"16","author":[{"given":"Dongning","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Congying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxia","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.14341\/probl.2024704","article-title":"Polycystic ovary syndrome: new and promising treatment methods","volume":"70","author":"Gasieva","year":"2024","journal-title":"Problemy endokrinologii"},{"key":"B2","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.3390\/ijerph19053089","article-title":"Neuroendocrine determinants of polycystic ovary syndrome","volume":"19","author":"Szeliga","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s10815-022-02625-7","article-title":"A brief insight into the etiology, genetics, and immunology of polycystic ovarian syndrome (PCOS)","volume":"39","author":"Siddiqui","year":"2022","journal-title":"J Assisted Reprod Genet"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(91)90280-5","article-title":"Adrenal and ovarian steroid hormone responses to gonadotropin-releasing hormone agonist treatment in polycystic ovary syndrome","volume":"165","author":"Gonzalez","year":"1991","journal-title":"Am J Obstetrics Gynecol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1530\/REP-15-0352","article-title":"Letrozole vs estradiol valerate induced PCOS in rats: glycemic, oxidative and inflammatory status assessment","volume":"151","author":"D\u0103neas\u0103","year":"2016","journal-title":"Reprod (Cambridge England)"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1210\/en.2017-00039","article-title":"Hyperhomocysteinemia promotes insulin resistance and adipose tissue inflammation in PCOS mice through modulating M2 macrophage polarization via estrogen suppression","volume":"158","author":"Qi","year":"2017","journal-title":"Endocrinol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"9782373","DOI":"10.1155\/2019\/9782373","article-title":"Mesenchymal stem cells alleviate DHEA-induced polycystic ovary syndrome (PCOS) by inhibiting inflammation in mice","volume":"2019","author":"Xie","year":"2019","journal-title":"Stem Cells Int"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-011-0263-y","article-title":"Immunotherapy with pluripotent stem cell-derived dendritic cells","volume":"33","author":"Senju","year":"2011","journal-title":"Semin Immunopathol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jri.2018.08.003","article-title":"Killer-cell immunoglobulin-like receptors associated with polycystic ovary syndrome","volume":"130","author":"Sala Elpidio","year":"2018","journal-title":"J Reprod Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1097\/JS9.0000000000001814","article-title":"The role of immune cell signatures in the pathogenesis of ovarian-related diseases: a causal inference based on Mendelian randomization","volume":"110","author":"Lu","year":"2024","journal-title":"Int J Surg"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.2741\/e695","article-title":"Polycystic ovary syndrome: current status and future perspective","volume":"6","author":"Barthelmess","year":"2014","journal-title":"Front Biosci (Elite edition)"},{"key":"B12","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s13048-023-01205-2","article-title":"Linkage and association of variants in the dopamine receptor 2 gene (DRD2) with polycystic ovary syndrome","volume":"16","author":"Amin","year":"2023","journal-title":"J Ovarian Res"},{"key":"B13","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1300\/J010v46n04_04","article-title":"Factors influencing health behaviors in the National Health and Nutritional Examination Survey, III (NHANES III)","volume":"46","author":"Barkley","year":"2008","journal-title":"Soc Work Health Care"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/ng.732","article-title":"Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3","volume":"43","author":"Chen","year":"2011","journal-title":"Nat Genet"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwae061","article-title":"Polycystic ovary syndrome and endometrial cancer risk: results from a nationwide cohort study","volume":"193","author":"Frandsen","year":"2024","journal-title":"Am J Epidemiol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1097\/GRF.0000000000000239","article-title":"Breast cancer epidemiology and risk factors","volume":"59","author":"Rojas","year":"2016","journal-title":"Clin Obstetrics Gynecol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.fertnstert.2018.08.021","article-title":"Beyond fertility: polycystic ovary syndrome and long-term health","volume":"110","author":"Cooney","year":"2018","journal-title":"Fertil Steril"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.17846","article-title":"PDGFRA, HSD17B4 and HMGB2 are potential therapeutic targets in polycystic ovarian syndrome and breast cancer","volume":"8","author":"Xu","year":"2017","journal-title":"Oncotarget"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dew243","article-title":"Insulin resistance in polycystic ovary syndrome: a systematic review and meta-analysis of euglycaemic-hyperinsulinaemic clamp studies","volume":"31","author":"Cassar","year":"2016","journal-title":"Hum Reprod (Oxford England)"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S168944","article-title":"Binge eating in patients with polycystic ovary syndrome: prevalence, causes, and management strategies","volume":"15","author":"Krug","year":"2019","journal-title":"Neuropsychiatr Dis Treat"},{"key":"B21","doi-asserted-by":"publisher","first-page":"Cd007506","DOI":"10.1002\/14651858.CD007506.pub4","article-title":"Lifestyle changes in women with polycystic ovary syndrome","volume":"3","author":"Lim","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"B22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1472-6874-1-3","article-title":"Diagnostic and treatment characteristics of polycystic ovary syndrome: descriptive measurements of patient perception and awareness from 657 confidential self-reports","volume":"1","author":"Sills","year":"2001","journal-title":"BMC Women\u2019s Health"},{"key":"B23","doi-asserted-by":"publisher","first-page":"869","DOI":"10.3390\/metabo11120869","article-title":"Metabolic syndrome and PCOS: pathogenesis and the role of metabolites","volume":"11","author":"Chen","year":"2021","journal-title":"Metabolites"},{"key":"B24","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1210\/er.2015-1104","article-title":"The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited","volume":"37","author":"Rosenfield","year":"2016","journal-title":"Endocr Rev"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2019.11.003","article-title":"Polycystic ovarian syndrome: Correlation between hyperandrogenism, insulin resistance and obesity","volume":"502","author":"Zeng","year":"2020","journal-title":"Clin Chim Acta"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.23736\/S2724-606X.22.05139-9","article-title":"Role of leptin, adiponectin, and kisspeptin in polycystic ovarian syndrome pathogenesis","volume":"75","author":"Nikolettos","year":"2023","journal-title":"Minerva Obstet Gynecol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"583","DOI":"10.3390\/ijms23020583","article-title":"Polycystic ovary syndrome: A comprehensive review of pathogenesis, management, and drug repurposing","volume":"23","author":"Sadeghi","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2023.07.025","article-title":"Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"120","author":"Teede","year":"2023","journal-title":"Fertil Steril"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmu012","article-title":"Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"20","author":"Barry","year":"2014","journal-title":"Hum Reprod Update"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/humupd\/6.1.1","article-title":"Leukocytes in ovarian function","volume":"6","author":"Bukulmez","year":"2000","journal-title":"Hum Reprod Update"},{"key":"B31","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jri.2011.09.003","article-title":"Systemic inflammation, cellular influx and up-regulation of ovarian VCAM-1 expression in a mouse model of polycystic ovary syndrome (PCOS)","volume":"92","author":"Solano","year":"2011","journal-title":"J Reprod Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06231-0","article-title":"B-cell-specific checkpoint molecules that regulate anti-tumour immunity","volume":"619","author":"Bod","year":"2023","journal-title":"Nature"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1326344","article-title":"Causal association of immune cells and polycystic ovarian syndrome: a Mendelian randomization study","volume":"14","author":"Aru","year":"2023","journal-title":"Front Endocrinol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1007\/s00109-024-02463-3","article-title":"PD-1\/PD-L1 axis: implications in immune regulation, cancer progression, and translational applications","volume":"102","author":"Ortega","year":"2024","journal-title":"J Mol Med (Berl)"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/s10815-024-03327-y","article-title":"Upregulation of PD-L1 contributes to improving the apoptosis of granulosa cells via the PI3K\/AKT pathway in PCOS","volume":"42","author":"Han","year":"2025","journal-title":"J Assist Reprod Genet"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxaa078","article-title":"IL-6 in inflammation, autoimmunity and cancer","volume":"33","author":"Hirano","year":"2021","journal-title":"Int Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0104797","article-title":"Evidence for a dopamine intrinsic direct role in the regulation of the ovary reproductive function: in vitro study on rabbit corpora lutea","volume":"9","author":"Parillo","year":"2014","journal-title":"PloS One"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02279","article-title":"Sex hormones in acquired immunity and autoimmune disease","volume":"9","author":"Moulton","year":"2018","journal-title":"Front Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-4177","article-title":"Evidence for decreased expression of ADAMTS-1 associated with impaired oocyte quality in PCOS patients","volume":"99","author":"Xiao","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.7150\/jca.87021","article-title":"Down-regulation of miR-424 inhibited the metastasis of endometrial carcinoma via targeting PTEN\/PI3K\/AKT signaling pathway","volume":"14","author":"Lu","year":"2023","journal-title":"J Cancer"},{"key":"B41","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1005740222307","article-title":"Molecular pathology of breast cancer and its application to clinical management","volume":"16","author":"Walker","year":"1997","journal-title":"Cancer Metastasis Rev"},{"key":"B42","doi-asserted-by":"publisher","first-page":"859","DOI":"10.3390\/ijms19030859","article-title":"Estrogen, angiogenesis, immunity and cell metabolism: solving the puzzle","volume":"19","author":"Trenti","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2019.1576613","article-title":"High prevalence of benign mammary tumors in a rat model of polycystic ovary syndrome during postmenopausal period","volume":"35","author":"Noroozzadeh","year":"2019","journal-title":"Gynecological Endocrinol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.5468\/ogs.2016.59.5.367","article-title":"The association between polycystic ovary syndrome and breast cancer: a meta-analysis","volume":"59","author":"Shobeiri","year":"2016","journal-title":"Obstetrics Gynecol Sci"},{"key":"B45","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ygyno.2014.11.012","article-title":"Risk of cancer among women with polycystic ovary syndrome: a Danish cohort study","volume":"136","author":"Gottschau","year":"2015","journal-title":"Gynecologic Oncol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-10-0747","article-title":"Oral contraceptive use and breast cancer: a prospective study of young women","volume":"19","author":"Hunter","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.v121.4","article-title":"Comparison of the roles of estrogens and androgens in breast cancer and prostate cancer","volume":"121","author":"Liu","year":"2020","journal-title":"J Cell Biochem"},{"key":"B48","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jri.2017.10.045","article-title":"The role of decidual immune cells on human pregnancy","volume":"124","author":"Liu","year":"2017","journal-title":"J Reprod Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.bpobgyn.2016.03.008","article-title":"Polycystic ovary syndrome: Endometrial markers","volume":"37","author":"Piltonen","year":"2016","journal-title":"Best Pract Res Clin Obstetrics Gynaecol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1097\/PPO.0000000000000595","article-title":"Hormone replacement therapy after breast cancer: it is time","volume":"28","author":"Bluming","year":"2022","journal-title":"Cancer J (Sudbury Mass)"},{"key":"B51","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/j.1749-6632.2001.tb03811.x","article-title":"Role of exogenous and endogenous hormones in endometrial cancer: review of the evidence and research perspectives","volume":"943","author":"Akhmedkhanov","year":"2001","journal-title":"Ann New York Acad Sci"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.75.5.1385468","article-title":"Steroid and peptide regulation of insulin-like growth factor-binding proteins secreted by human endometrial stromal cells is dependent on stromal differentiation","volume":"75","author":"Giudice","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-20-1613","article-title":"Sex hormones, insulin, and insulin-like growth factors in recurrence of high-stage endometrial cancer","volume":"30","author":"Merritt","year":"2021","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.1998.4941","article-title":"Evidence for a common etiology for endometrial carcinomas and Malignant mixed mullerian tumors","volume":"69","author":"Zelmanowicz","year":"1998","journal-title":"Gynecologic Oncol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/71.3.253","article-title":"Histologic study of ovaries from young women with endometrial adenocarcinoma","volume":"71","author":"Ramzy","year":"1979","journal-title":"Am J Clin Pathol"},{"key":"B56","article-title":"Adenocarcinoma of the endometrium in women 40 years of age or younger","volume":"64","author":"Gallup","year":"1984","journal-title":"Obstetrics Gynecol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1080\/1464727002000198781","article-title":"Long-term consequences of polycystic ovary syndrome: results of a 31 year follow-up study","volume":"3","author":"Wild","year":"2000","journal-title":"Hum Fertil (Cambridge England)"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000002698","article-title":"Polycystic ovary syndrome","volume":"132","author":"Azziz","year":"2018","journal-title":"Obstetrics Gynecol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1002\/ijgo.2018.142.issue-2","article-title":"Endometrial neoplasia in reproductive-aged Thai women with polycystic ovary syndrome","volume":"142","author":"Indhavivadhana","year":"2018","journal-title":"Int J Gynaecol Obstetrics"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-007-0681-5","article-title":"Diabetes mellitus and risk of endometrial cancer: a meta-analysis","volume":"50","author":"Friberg","year":"2007","journal-title":"Diabetologia"},{"key":"B61","doi-asserted-by":"publisher","first-page":"R25","DOI":"10.1530\/REP-19-0501","article-title":"The ovarian stroma as a new frontier","volume":"160","author":"Kinnear","year":"2020","journal-title":"Reprod (Cambridge England)"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwv308","article-title":"Lifetime number of ovulatory cycles and risks of ovarian and endometrial cancer among postmenopausal women","volume":"183","author":"Yang","year":"2016","journal-title":"Am J Epidemiol"},{"key":"B63","article-title":"Androgen receptors in ovarian tumors: correlation with oestrogen and progesterone receptors in an immunohistochemical and semiquantitative image analysis study","volume":"17","author":"Cardillo","year":"1998","journal-title":"J Exp Clin Cancer Res: CR"},{"key":"B64","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12902-019-0356-5","article-title":"Genetic and epigenetic characteristics in ovarian tissues from polycystic ovary syndrome patients with irregular menstruation resemble those of ovarian cancer","volume":"19","author":"Jiao","year":"2019","journal-title":"BMC Endocr Disord"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.4067\/s0034-98872017000700907","article-title":"Epigenetics of polycystic ovary syndrome","volume":"145","author":"Concha","year":"2017","journal-title":"Rev Med Chile"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1677\/ERC-08-0075","article-title":"Epithelial ovarian cancer: testing the \u2018androgens hypothesis\u2019","volume":"15","author":"Olsen","year":"2008","journal-title":"Endocrine-related Cancer"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2019.10.011","article-title":"Controversial association between polycystic ovary syndrome and breast cancer","volume":"243","author":"Carvalho","year":"2019","journal-title":"Eur J Obstetrics Gynecol Reprod Biol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/0029-7844(96)00226-8","article-title":"Epithelial ovarian cancer risk among women with polycystic ovary syndrome","volume":"88","author":"Schildkraut","year":"1996","journal-title":"Obstetrics Gynecol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"893","DOI":"10.18502\/ijrm.v20i11.12357","article-title":"Risk of endometrial, ovarian, and breast cancers in women with polycystic ovary syndrome: A systematic review and meta-analysis","volume":"20","author":"Amiri","year":"2022","journal-title":"Int J Reprod BioMed"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.v153.5","article-title":"Risk of epithelial ovarian tumors among women with polycystic ovary syndrome: A nationwide population-based cohort study","volume":"153","author":"Frandsen","year":"2023","journal-title":"Int J Cancer"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/0090-8258(90)90109-X","article-title":"Treatment of endometrial stromal tumors","volume":"36","author":"Berchuck","year":"1990","journal-title":"Gynecologic Oncol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1054\/bjoc.1999.1038","article-title":"Expression of oestrogen and progesterone receptors in low-grade endometrial stromal sarcomas","volume":"82","author":"Reich","year":"2000","journal-title":"Br J Cancer"},{"key":"B73","article-title":"Malignant mixed mesodermal tumor in a young woman with polycystic ovary syndrome. A case report","volume":"47","author":"Karabakhtsian","year":"2002","journal-title":"J Reprod Med"},{"key":"B74","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/PAP.0000000000000478","article-title":"Risk stratification of uterine smooth muscle tumors: the role of morphology, immunohistochemistry, and molecular testing","volume":"32","author":"Momeni-Boroujeni","year":"2025","journal-title":"Adv Anat Pathol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae256","article-title":"Depression, anxiety, and risk of metabolic syndrome in women with polycystic ovary syndrome: A longitudinal study","volume":"3","author":"Lee","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0035-5","article-title":"Elevated prenatal anti-M\u00fcllerian hormone reprograms the fetus and induces polycystic ovary syndrome in adulthood","volume":"24","author":"Tata","year":"2018","journal-title":"Nat Med"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab422","article-title":"Targeting elevated gnRH pulsatility to treat polycystic ovary syndrome","volume":"106","author":"Abbara","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"B78","doi-asserted-by":"publisher","first-page":"104850","DOI":"10.1016\/j.ebiom.2023.104850","article-title":"Overactivation of GnRH neurons is sufficient to trigger polycystic ovary syndrome-like traits in female mice","volume":"97","author":"Silva","year":"2023","journal-title":"EBioMed"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13578","article-title":"Polycystic ovary syndrome revisited: An interactions network approach","volume":"51","author":"Geronikolou","year":"2021","journal-title":"Eur J Clin Investigation"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-1202","article-title":"Neurokinin B receptor antagonism in women with polycystic ovary syndrome: A randomized, placebo-controlled trial","volume":"101","author":"George","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B81","doi-asserted-by":"publisher","first-page":"18","DOI":"10.4103\/jpgm.JPGM_683_17","article-title":"Polycystic ovary syndrome (PCOS) and kisspeptin - A Sri Lankan study","volume":"65","author":"Umayal","year":"2019","journal-title":"J Postgraduate Med"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-019-06001-x","article-title":"Disturbed gastrointestinal contractility in a polycystic ovary syndrome rat model","volume":"65","author":"Wang","year":"2020","journal-title":"Digestive Dis Sci"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2015.12.020","article-title":"Serum metabolomics study of Traditional Chinese medicine formula intervention to polycystic ovary syndrome","volume":"120","author":"Lu","year":"2016","journal-title":"J Pharmaceutical Biomed Analysis"},{"key":"B84","doi-asserted-by":"publisher","first-page":"118731","DOI":"10.1016\/j.lfs.2020.118731","article-title":"Liraglutide mends cognitive impairment by averting Notch signaling pathway overexpression in a rat model of polycystic ovary syndrome","volume":"265","author":"Saad","year":"2021","journal-title":"Life Sci"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-022-03074-0","article-title":"Protective role of acetate against depressive-like behaviour associated with letrozole-induced PCOS rat model: involvement of HDAC2 and DNA methylation","volume":"60","author":"Wolugbom","year":"2023","journal-title":"Mol Neurobiol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.18502\/jri.v23i3.10006","article-title":"Nesfatin-1, dopamine, and NADPH levels in infertile women with polycystic ovary syndrome: is there a relationship between their levels and metabolic and hormonal variables","volume":"23","author":"Hamed","year":"2022","journal-title":"J Reprod Infertil"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1016\/0028-2243(89)90134-2","article-title":"Increased dopamine turnover in women with polycystic ovary syndrome","volume":"33","author":"Segos","year":"1989","journal-title":"Eur J Obstetrics Gynecol Reprod Biol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"17455057221117966","DOI":"10.1177\/17455057221117966","article-title":"An update on polycystic ovary syndrome: A review of the current state of knowledge in diagnosis, genetic etiology, and emerging treatment options","volume":"18","author":"Islam","year":"2022","journal-title":"Women\u2019s Health (London England)"},{"key":"B89","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1210\/er.2015-1018","article-title":"Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome","volume":"36","author":"Dumesic","year":"2015","journal-title":"Endocr Rev"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2022.02.028","article-title":"Subclinical cardiovascular disease and polycystic ovary syndrome","volume":"117","author":"Gomez","year":"2022","journal-title":"Fertil Steril"},{"key":"B91","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s12916-025-03901-w","article-title":"International evidence-based recommendations for polycystic ovary syndrome in adolescents","volume":"23","author":"Pena","year":"2025","journal-title":"BMC Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1578470\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T05:39:35Z","timestamp":1749015575000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1578470\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,4]]},"references-count":91,"alternative-id":["10.3389\/fimmu.2025.1578470"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1578470","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,4]]},"article-number":"1578470"}}